Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
ABOUT THIS PAGE
83
PharmaCompass offers a list of N-Methyl Amisulpride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right N-Methyl Amisulpride manufacturer or N-Methyl Amisulpride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred N-Methyl Amisulpride manufacturer or N-Methyl Amisulpride supplier.
PharmaCompass also assists you with knowing the N-Methyl Amisulpride API Price utilized in the formulation of products. N-Methyl Amisulpride API Price is not always fixed or binding as the N-Methyl Amisulpride Price is obtained through a variety of data sources. The N-Methyl Amisulpride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A N-Methyl Amisulpride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N-Methyl Amisulpride, including repackagers and relabelers. The FDA regulates N-Methyl Amisulpride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N-Methyl Amisulpride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A N-Methyl Amisulpride supplier is an individual or a company that provides N-Methyl Amisulpride active pharmaceutical ingredient (API) or N-Methyl Amisulpride finished formulations upon request. The N-Methyl Amisulpride suppliers may include N-Methyl Amisulpride API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing N-Methyl Amisulpride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for N-Methyl Amisulpride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture N-Methyl Amisulpride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain N-Methyl Amisulpride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a N-Methyl Amisulpride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of N-Methyl Amisulpride suppliers with NDC on PharmaCompass.
N-Methyl Amisulpride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N-Methyl Amisulpride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N-Methyl Amisulpride GMP manufacturer or N-Methyl Amisulpride GMP API supplier for your needs.
A N-Methyl Amisulpride CoA (Certificate of Analysis) is a formal document that attests to N-Methyl Amisulpride's compliance with N-Methyl Amisulpride specifications and serves as a tool for batch-level quality control.
N-Methyl Amisulpride CoA mostly includes findings from lab analyses of a specific batch. For each N-Methyl Amisulpride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N-Methyl Amisulpride may be tested according to a variety of international standards, such as European Pharmacopoeia (N-Methyl Amisulpride EP), N-Methyl Amisulpride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N-Methyl Amisulpride USP).
